Adult
Aged
Antimetabolites, Antineoplastic
/ therapeutic use
Biomarkers, Tumor
/ genetics
Cell Adhesion Molecules
/ genetics
Chemotherapy, Adjuvant
/ methods
Cohort Studies
Colorectal Neoplasms
/ drug therapy
Disease-Free Survival
Female
Fluorouracil
/ therapeutic use
Gene Expression
Humans
Leucovorin
/ therapeutic use
Male
Middle Aged
Neoplasm Staging
Nuclear Proteins
/ genetics
Potassium Channels, Voltage-Gated
/ genetics
Prognosis
Pyrimidines
/ therapeutic use
RNA, Messenger
/ metabolism
Treatment Outcome
Journal
Oncology research
ISSN: 1555-3906
Titre abrégé: Oncol Res
Pays: United States
ID NLM: 9208097
Informations de publication
Date de publication:
16 Mar 2021
16 Mar 2021
Historique:
pubmed:
20
11
2020
medline:
21
8
2021
entrez:
19
11
2020
Statut:
ppublish
Résumé
The benefit of adjuvant chemotherapy in the early stages of colorectal cancer (CRC) is still disappointing and the prediction of treatment outcome quite difficult. Recently, through a transcriptomic approach, we evidenced a role of
Identifiants
pubmed: 33208224
doi: 10.3727/096504020X16056983169118
pmc: PMC7962934
doi:
Substances chimiques
Antimetabolites, Antineoplastic
0
Biomarkers, Tumor
0
Cell Adhesion Molecules
0
KCNQ1OT1 long non-coding RNA, human
0
Nuclear Proteins
0
PNN protein, human
0
Potassium Channels, Voltage-Gated
0
Pyrimidines
0
RNA, Messenger
0
5-fluoropyrimidine
675-21-8
Leucovorin
Q573I9DVLP
Fluorouracil
U3P01618RT
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
631-644Références
J Cell Physiol. 2020 Feb;235(2):1543-1555
pubmed: 31313837
Lancet. 1995 Apr 15;345(8955):939-44
pubmed: 7715291
Nat Commun. 2017 May 31;8:15107
pubmed: 28561063
JAMA Oncol. 2019 Dec 1;5(12):1749-1768
pubmed: 31560378
JAMA Oncol. 2016 Sep 1;2(9):1162-9
pubmed: 27270348
Arch Biochem Biophys. 2018 Nov 15;658:7-15
pubmed: 30243712
J Cell Mol Med. 2019 Jun;23(6):3808-3823
pubmed: 30997746
Int J Oncol. 2018 May;52(5):1603-1612
pubmed: 29532864
Clin Cancer Res. 2008 May 1;14(9):2749-55
pubmed: 18451241
Aging (Albany NY). 2018 Apr 17;10(4):632-644
pubmed: 29667930
J Clin Oncol. 2004 Feb 1;22(3):529-36
pubmed: 14752076
JCO Precis Oncol. 2018 Jun 13;2018:
pubmed: 30088816
Mol Ther Nucleic Acids. 2019 Sep 6;17:804-818
pubmed: 31454677
Cell Death Dis. 2018 Jul 3;9(7):742
pubmed: 29970910
Nat Med. 2015 Nov;21(11):1350-6
pubmed: 26457759
Oncogene. 1999 Aug 26;18(34):4777-87
pubmed: 10490811
J Clin Oncol. 2015 Jun 1;33(16):1787-96
pubmed: 25918287
J Cell Sci. 2012 Jul 1;125(Pt 13):3164-72
pubmed: 22454513
Cell Physiol Biochem. 2018;49(5):1778-1791
pubmed: 30231249
Onco Targets Ther. 2019 Apr 09;12:2649-2660
pubmed: 31040703
Nat Rev Cancer. 2018 Nov;18(11):696-705
pubmed: 30293088
Nat Rev Clin Oncol. 2020 Jan;17(1):11-32
pubmed: 31289352
Biochem Biophys Res Commun. 1999 Sep 16;263(1):192-200
pubmed: 10486276
Biochem Cell Biol. 2020 Jun;98(3):338-344
pubmed: 32379482
JAMA Oncol. 2018 Mar 1;4(3):379-383
pubmed: 28983557
Int J Cancer. 2019 Nov 1;145(9):2580-2593
pubmed: 30973654
Biochem Biophys Res Commun. 2002 Jun 7;294(2):448-55
pubmed: 12051732
Oncotarget. 2016 Mar 8;7(10):11397-411
pubmed: 26871283
Nat Rev Gastroenterol Hepatol. 2019 Feb;16(2):79-80
pubmed: 30575801
Science. 2013 Mar 29;339(6127):1546-58
pubmed: 23539594
BMC Cancer. 2013 Mar 17;13:123
pubmed: 23496812
Mol Cell Biol. 2008 Mar;28(5):1584-95
pubmed: 18086895
Differentiation. 1997 Dec;62(3):119-27
pubmed: 9447706
Cell Physiol Biochem. 2018;49(2):432-446
pubmed: 30157476
Oncogene. 2004 Apr 15;23(17):2977-87
pubmed: 15021917
Front Genet. 2020 Feb 17;11:69
pubmed: 32127798
Nature. 2020 Feb;578(7793):82-93
pubmed: 32025007
N Engl J Med. 2019 Oct 24;381(17):1632-1643
pubmed: 31566309
Oncogene. 2000 Jan 13;19(2):289-97
pubmed: 10645008
Cancer Discov. 2018 Feb;8(2):184-195
pubmed: 29247021
Cancer Cell Int. 2020 May 1;20:144
pubmed: 32377169
Front Cell Neurosci. 2017 Mar 22;11:84
pubmed: 28381990
Oncotarget. 2016 May 17;7(20):29429-39
pubmed: 27107420
Mol Oncol. 2020 Sep;14(9):2251-2270
pubmed: 32364663
Oncotarget. 2016 Jun 28;7(26):39694-39704
pubmed: 27175589
Ann Oncol. 2020 Jul;31(7):921-929
pubmed: 32294529
Hum Mol Genet. 2001 Mar 1;10(5):467-76
pubmed: 11181570
Sci Rep. 2016 Feb 12;6:20690
pubmed: 26868975
Eur J Cancer. 2017 Sep;82:16-24
pubmed: 28651158
Int J Cancer. 2011 Apr 15;128(8):1935-45
pubmed: 20560137
Nature. 2012 Jul 18;487(7407):330-7
pubmed: 22810696
Clin Cancer Res. 2018 Oct 1;24(19):4745-4753
pubmed: 29921730
Thorac Cancer. 2018 May;9(5):523-531
pubmed: 29504267
Eur J Cancer. 2021 Feb;144:101-112
pubmed: 33341444
Nat Rev Mol Cell Biol. 2018 Mar;19(3):143-157
pubmed: 29138516
Cancer Chemother Pharmacol. 2017 Aug;80(2):243-250
pubmed: 28600629
J Cell Physiol. 2019 Jul;234(7):11304-11314
pubmed: 30471108
J Cell Biol. 1992 Sep;118(6):1477-88
pubmed: 1522118
Eur Rev Med Pharmacol Sci. 2020 Jan;24(1):200-212
pubmed: 31957833
Biochem Biophys Res Commun. 2014 Sep 26;452(3):614-21
pubmed: 25181339
Hum Mol Genet. 2012 Jan 1;21(1):10-25
pubmed: 21920939
Jpn J Cancer Res. 2002 Aug;93(8):888-93
pubmed: 12716466
Clin Cancer Res. 2016 Aug 15;22(16):4057-66
pubmed: 26994146
Science. 2017 Jul 28;357(6349):409-413
pubmed: 28596308
Ann Oncol. 2017 May 1;28(5):1023-1031
pubmed: 28453697
J Natl Cancer Inst. 2016 Dec 31;109(5):
pubmed: 28040692